Impact of hypertension on coronary artery spasm as assessed with intracoronary acetylcholine provocation test

Journal of Human Hypertension

Volumn 24, Issue 2, 2010, Pages 77-85

  Chen, K Y ^a   Rha, S W ^a   Li, Y J ^a   Poddar, K L ^a   Jin, Z ^a   Minami, Y ^b   Saito, S ^b   Park, J H ^a   Na, J O ^a   Choi, C U ^a   Lim, H E ^a   Kim, J W ^a   Kim, E J ^a   Park, C G ^a   Seo, H S ^a   Oh, D J ^a  

^a Korea University College of Medicine   (South Korea)

^b SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

Acetylcholine; Blood pressure control; Coronary artery spasm

Indexed keywords

ACETYLCHOLINE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CORONARY ARTERY SPASM; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROVOCATION TEST; RISK ASSESSMENT; RISK FACTOR;

ACETYLCHOLINE; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERTENSION; INJECTIONS, INTRA-ARTERIAL; KOREA; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 75149121939     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.40     Document Type: Article

References (24)

1. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534-2544.
2. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27-III32.
3. Lavi S, Yang EH, Prasad A, Mathew V, Barsness GW, Rihal CS et al. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 2008; 51: 127-133.
4. Kugiyama K, Murohara T, Yasue H, Kimura T, Sakaino N, Ohgushi M et al. Increased constrictor response to acetylcholine of the isolated coronary arteries from patients with variant angina. Int J Cardiol 1995; 52: 223-233.
5. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996; 94: 266-271.
6. Kugiyama K, Ohgushi M, Motoyama T, Sugiyama S, Ogawa H, Yoshimura M et al. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1997; 30: 920-926.
7. Takaoka K, Yoshimura M, Ogawa H, Kugiyama K, Nakayama M, Shimasaki Yet al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol 2000; 72: 121-126.
8. Xiang D, Kleber FX. Smoking and hyperlipidemia are important risk factors for coronary artery spasm. Chin Med J (Engl) 2003; 116: 510-513.
9. Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y et al. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis 2004; 15: 491-497.
10. Kim JW, Park CG, Suh SY, Choi CU, Kim EJ, Rha SW et al. Comparison of frequency of coronary spasm in korean patients with versus without myocardial bridging. Am J Cardiol 2007; 100: 1083-1086.
11. Kim JW, Seo HS, Na JO, Suh SY, Choi CU, Kim EJ et al. Myocardial bridging is related to endothelial dysfunction but not to plaque as assessed by intracoronary ultrasound. Heart 2008; 94: 765-769.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
13. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 2008; 51: 1742-1748.
14. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005; 165: 1410-1419.
15. Mancia G, Messerli F, Bakris G, Zhou Q, Champion A, Pepine CJ. Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study. Hypertension 2007; 50: 299-305.
16. Newman CM, Maseri A, Hackett DR, el-Tamimi HM, Davies GJ. Response of angiographically normal and atherosclerotic left anterior descending coronary arteries to acetylcholine. Am J Cardiol 1990; 66: 1070-1076.
17. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
18. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986; 74: 955-963.
19. Houghton JL, Davison CA, Kuhner PA, Torossov MT, Strogatz DS, Carr AA. Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension. J Am Coll Cardiol 1998; 31: 374-382.
20. Houghton JL, Strogatz DS, Torosoff MT, Smith VE, Fein SA, Kuhner PA et al. African Americans with LVH demonstrate depressed sensitivity of the coronary microcirculation to stimulated relaxation. Hypertension 2003; 42: 269-276.
21. Kido S, Ishii Y, Hasebe N, Ido A, Kawashima E, Ogawa Y et al. Significance of coronary risk factors and coronary arteriosclerosis for coronary vasospasm. J Cardiol 1998; 31: 135-143.
22. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993; 87: 76-79.
23. Barac A, Campia U, Panza JA. Methods for evaluating endothelial function in humans. Hypertension 2007; 49: 748-760.
24. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93.